Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
08/2005
08/17/2005EP1562937A2 N-substituted piperidine derivatives as serotonin receptor agents
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP0991638B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS
08/17/2005CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
08/17/2005CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives
08/17/2005CN1215030C 1, 4-diaryl-2-fluoro-2-butene insecticidal and acaricidal agents
08/16/2005CA2323707C New substances derived from benzothiophenes, benzofurans and indolics, processes for preparing them and pharmaceutical compounds containing them
08/11/2005US20050176967 Alkylating 4-amino-1,2,4-triazole with a stearically hindered methyl oxirane; chemical intermediates, fungicidal compositions for cereal diseases
08/11/2005US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors
08/11/2005DE102004003958A1 Herstellungsmethode für ionische Flüssigkeiten Method of preparation of ionic liquids
08/11/2005DE102004002420A1 Destillation von ionischen Flüssigkeiten Distillation of ionic liquids
08/10/2005EP1333795A4 Novel coupler for use in oxidative hair dyeing
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1214012C Method for producing carbonyl dimidazoles
08/09/2005CA2162920C Process for the production of aminoalkylguanidines
08/04/2005WO2005070923A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
08/04/2005WO2005070896A1 Mehtod for producing ionic liquids
08/04/2005US20050171156 Prodrugs of potassium channel inhibitors
08/04/2005US20050171134 such as 4-[4-(1-Amino-1-methylethyl)phenyl]-5-chloro-N-[4-(2-hydroxyethyl)phenyl]pyrimidine-2-amine used as tyrosine kinase inhibitors, for prophylaxis disease states associated with angiogenesis
08/03/2005EP1087948B1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
08/03/2005CN1649866A 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
08/03/2005CN1649865A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/03/2005CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213035C 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
08/02/2005US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases
08/02/2005US6923835 Hair dyes comprising heterocyclic amines such as N,N'-bis[1-(4-aminophenyl)pyrrolidin-3-yl]-N,N,N',N'-tetramethylhexane-1,6-diaminium dichloride having colorfastness and chemical resistance
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068404A1 Distillation of ionic liquids
07/28/2005WO2004093828A3 Reverse-turn mimetics and method relating thereto
07/28/2005WO2002096905A8 Thiazole compounds useful as inhibitors of protein kinases
07/28/2005US20050165062 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
07/28/2005US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology
07/27/2005EP1557410A2 Bacterial gyrase inhibitors and uses thereof
07/27/2005EP1387837B1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines
07/27/2005EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists
07/27/2005EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas
07/27/2005EP0929526B1 Qinoline derivatives inhibiting the effect of growth factors such as vegf
07/27/2005CN1646546A Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
07/27/2005CN1646545A Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates
07/21/2005US20050159473 3-Substituted oxindole beta3 agonists
07/20/2005EP1554253A1 Imidazolium cxcr3 inhibitors
07/20/2005EP1303514B1 Process for preparing azacycloalkanoylaminothiazoles
07/20/2005EP1303512B1 Process for preparing arylacetylaminothiazoles
07/20/2005EP1268396B1 Diphenyl ether compounds useful in therapy
07/20/2005CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
07/20/2005CN1211362C New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them
07/19/2005US6919461 Anticancer agents; antiarthritic agents
07/19/2005US6919363 Central nervous system disorders; antiischemic agents; analgesics
07/19/2005US6919361 Five-membered-ring compound
07/19/2005US6919358 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
07/19/2005US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
07/14/2005US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance
07/14/2005US20050154202 Substituted aryl amides
07/14/2005US20050154027 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
07/14/2005US20050153996 Compounds that modulate ppar activity and methods for their preparation
07/14/2005US20050153980 Substituted indoles
07/14/2005DE10358082A1 Organübergangsmetallverbindung, Bscyclopentadienyligandsystem, Katalysatorsystem und Hertellung von Polyolefinen Organ transition metal compound Bscyclopentadienyligandsystem, catalyst system and Hertel averaging of polyolefins
07/13/2005EP1553097A1 Quinazoline derivatives as angiogenesis inhibitors and intermediates therefore
07/13/2005CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/13/2005CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
07/13/2005CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides
07/13/2005CN1210265C Phthalazine derivatives and remedies for erectile dysfunction
07/12/2005US6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase
07/12/2005US6916347 Making 2-amino-5-substituted-amino-phenol derivatives by reduction, hydrogenation, amination, hydroxylation; oxidation color dyes, hair dye mixture including coupler and developer oxidizers, yellow color shades, colorfastness
07/12/2005CA2341739C Quinolin-2-one derivatives useful as anticancer agents
07/07/2005US20050148778 One pot, industrial scale, low cost synthesis; forming diazonium salt of 4-[1,2,4]triazol-1ylmethyl-aniline HCL, reducing, acidifying; reacting intermediate with keto-valerolactone then fischer indole converting followed by transesterification, amination, saponification decarboxylation
07/07/2005US20050148581 Quinolines; 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum; reduces the total length of treatment and the frequency of drug administration; multi-drug and antibiotic resistance
07/06/2005EP1549621A1 Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes
07/06/2005EP1549600A1 Ketones
07/06/2005EP1140909B1 Novel inhibitors of farnesyl-protein transferase
07/06/2005CN1636000A 5-substituted arylpyrimidines
07/06/2005CN1209016C Fungicides
07/05/2005US6914160 Oxytocin inhibitors
06/2005
06/30/2005WO2005058916A2 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins
06/29/2005EP1546158A1 Azole derivatives as antifungal agents
06/29/2005EP1546107A1 Cox-2 inhibiting pyridine derivatives
06/29/2005EP1545543A2 Novel tyrosine kinases inhibitors
06/29/2005CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
06/28/2005US6911463 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity
06/28/2005US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
06/23/2005WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor
06/22/2005EP1542997A2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
06/22/2005EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor
06/22/2005EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors
06/22/2005CN1630654A R- - -1- [2- 7-chlorobenzo [b] thiophen-3 -yl- methoxy -2- 2, 4-dichlorophenyl -ethyl] -1h-imidazole
06/22/2005CN1630651A Novel gamma secretase inhibitors
06/22/2005CN1630646A Optically active azole derivative and process for producing the same
06/22/2005CN1630641A Farnesyl protein transferase inhibitors as antitumor agents
06/22/2005CN1207286C Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds
06/21/2005US6908884 For agriculture/horticulture/crops
06/21/2005CA2231143C Farnesyl transferase inhibiting 2-quinolone derivatives
06/16/2005US20050131041 Using trizole or imidazole compound containing hydroxy group
06/15/2005EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
06/15/2005EP1539747A1 N-aroyl cyclic amines as orexin receptor antagonists
06/15/2005EP1539724A1 Amino benzothiazole compounds with nos inhibitory activity
06/15/2005EP1539708A1 Benzimidazolones and their use as cytokine inhibitors
06/15/2005EP1539163A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 163